Retension Pharmaceuticals, Inc. (RTSN)

NASDAQ

$15.16

$-0.51

(-3.29%)

Previous Close: ⁦$15.50⁩

Market Closed

Retension Pharmaceuticals, Inc. (RTSN) Live Price Chart

Last updated: ⁦2026-10-24 16:17:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Retension Pharmaceuticals, Inc. (RTSN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $15.16, with a market capitalization of $129.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.66 to $18.64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$129.14M
Open	$15.85
Day's High	$18.64
Day's Low	$9.66
Previous Close	$15.50
Volume	76.77K
Average Volume	199.79K
P/E Ratio	--
52-Week High	$18.64
52-Week Low	$9.66
Dividend Yield	--
Earnings Date	--

Retension Pharmaceuticals, Inc. (RTSN) Latest Closing Stock Price

Retension Pharmaceuticals, Inc. (RTSN) last closed at $15.50 as of 2026-10-23 23:31:00, unchanged from the previous close of $15.50.

During the latest regular trading session, RTSN traded between $9.66 and $18.64, with a volume of 76.77K shares. The closing price was near the middle and near the middle of its 52-week range.

Retension Pharmaceuticals, Inc. (RTSN) 7-Day Stock Price Change

Over the past seven days, Retension Pharmaceuticals, Inc. (RTSN) moved from $12.21 to $15.16, representing a gain of 24.16% ($2.95).

The stock traded between $11.56 and $18.64 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 145.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

RTSN 52-Week Price Position

Position in Range: 61.2%

52W Low$9.66

52W High$18.64

RTSN is currently trading at $15.16, placing it 61.2% of the way from its 52-week low of $9.66 to its 52-week high of $18.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Retension Pharmaceuticals, Inc. (RTSN)?

Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.

Retension Pharmaceuticals, Inc. Information

Exchange	NASDAQ
Company Website	https://www.retensionpharmaceuticals.com

How to Buy Retension Pharmaceuticals, Inc. (RTSN) Stock on MEXC

Eligible investors can buy real shares of Retension Pharmaceuticals, Inc. (RTSN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RTSN and Place Your Order

Open the RealStocks trading page and search for RTSN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Retension Pharmaceuticals, Inc. (RTSN) stock price today?

Retension Pharmaceuticals, Inc. (RTSN) is currently trading at $ 15.16, down 2.19% ($0.34) from the previous close of $ 15.50. Intraday prices update in real time during regular trading hours.

2.Is RTSN stock going up or down today?

As of 2026-10-23 23:31:00, RTSN is trading at $ 15.16, down 2.19% ($0.34) from its previous close of $ 15.50. The stock has traded between $ 9.66 and $ 18.64 during today’s regular session. Past price movements do not guarantee future results.

3.What is RTSN pre-market price?

As of 2026-10-23 23:31:00, RTSN is trading at $ 16.55 in pre-market trading, up 6.74% ($1.05) from the previous close of $ 15.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RTSN after-hours price?

As of 2026-10-23 23:31:00, RTSN is trading at $ 14.73 in after-hours trading, down 5.00% ($0.78) from the regular-session close of $ 15.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RTSN stock trading now?

RTSN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RTSN sit relative to its 52-week high and low?

Over the past 52 weeks, RTSN has traded between a low of $ 9.66 and a high of $ 18.64. At $ 15.16, the stock is positioned 61.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Retension Pharmaceuticals, Inc. in?

Retension Pharmaceuticals, Inc. (RTSN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Retension Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Retension Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 129.14M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RTSN valued in terms of P/E ratio and EPS?

RTSN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Retension Pharmaceuticals, Inc. pay a dividend?

Retension Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.